Paper Details

  1. Home
  2. Paper Details

Interferon after surgery for women with advanced (Stage II-IV) epithelial ovarian cancer.

Author: GroblerLiesl, LawalAramide O, MusekiwaAlfred

Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Meta-AnalysisA statistical technique that integrates the results of multiple studies to draw more general conclusions about a particular issue.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.
ReviewAn article that critically examines existing research on a particular topic and summarizes the current state of knowledge in the field.
Systematic ReviewA review that systematically collects, evaluates, and integrates relevant research to answer a specific research question.

Overview

Epithelial ovarian cancer is a serious disease that is often diagnosed at a late stage, making treatment more challenging. While surgery and chemotherapy are effective, the cancer often comes back. New treatments are needed to prevent recurrence, improve survival, and increase quality of life for women with ovarian cancer.
Paper Details　
Original Abstract of the Article :
Epithelial ovarian cancer (EOC) is a life-threatening disease. Most often women become symptomatic only in the advanced stages of the disease, increasing the difficulty of treatment. Whilst the disease responds well to surgery and chemotherapy, the relapse rate is high. New treatments to prevent dis...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6457675/

データ提供：米国国立医学図書館（NLM）

Interferon: A New Weapon in the Fight Against Ovarian Cancer

This study delves into the challenging world of epithelial ovarian cancer (EOC), a disease that can be as formidable as a sandstorm in the desert. The research explores the potential benefits of interferon, a naturally occurring protein that can stimulate the immune system, as a post-surgical treatment for advanced EOC. The study seeks to determine whether interferon can help prevent disease recurrence or progression, potentially improving survival outcomes and quality of life for patients with this difficult-to-treat cancer.

Interferon: A Potential Oasis in the Desert of Ovarian Cancer Treatment

The study highlights the potential of interferon as a post-surgical treatment for advanced EOC, offering a glimmer of hope in the desert of this challenging disease. The research team aims to investigate whether interferon can help prevent disease recurrence or progression, potentially improving survival outcomes and quality of life for patients with this difficult-to-treat cancer. The study's findings could have significant implications for the future management of EOC, offering a potentially transformative approach to treatment.

Navigating the Desert of Ovarian Cancer

This research offers hope for patients with advanced EOC, exploring the potential of interferon as a new weapon in the fight against this challenging disease. It is important to note that this is an ongoing area of research, and more studies are needed to fully understand the role of interferon in EOC treatment. However, the study's design suggests a promising approach to post-surgical management, potentially offering a new path through the desert of EOC treatment.

Dr.Camel's Conclusion

This study explores the potential of interferon as a post-surgical treatment for advanced EOC, offering a glimmer of hope in the desert of this challenging disease. Further research is needed to confirm its efficacy and safety, but the study's findings suggest a potentially valuable new tool for managing this difficult-to-treat cancer.
Date :
  1. Date Completed 2013-11-19
  2. Date Revised 2022-09-02
Further Info :

Pubmed ID

23740789

DOI: Digital Object Identifier

PMC6457675

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.